4dva
From Proteopedia
(Difference between revisions)
(One intermediate revision not shown.) | |||
Line 1: | Line 1: | ||
==The crystal structure of human urokinase-type plasminogen activator catalytic domain== | ==The crystal structure of human urokinase-type plasminogen activator catalytic domain== | ||
- | <StructureSection load='4dva' size='340' side='right' caption='[[4dva]], [[Resolution|resolution]] 1.94Å' scene=''> | + | <StructureSection load='4dva' size='340' side='right'caption='[[4dva]], [[Resolution|resolution]] 1.94Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[4dva]] is a 1 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[4dva]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4DVA OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4DVA FirstGlance]. <br> |
- | </td></tr><tr id=' | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.94Å</td></tr> |
- | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=P6G:HEXAETHYLENE+GLYCOL'>P6G</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | |
- | <tr id=' | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4dva FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4dva OCA], [https://pdbe.org/4dva PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4dva RCSB], [https://www.ebi.ac.uk/pdbsum/4dva PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4dva ProSAT]</span></td></tr> |
- | + | ||
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
- | == Disease == | ||
- | [[http://www.uniprot.org/uniprot/UROK_HUMAN UROK_HUMAN]] Defects in PLAU are the cause of Quebec platelet disorder (QPD) [MIM:[http://omim.org/entry/601709 601709]]. QPD is an autosomal dominant bleeding disorder due to a gain-of-function defect in fibrinolysis. Although affected individuals do not exhibit systemic fibrinolysis, they show delayed onset bleeding after challenge, such as surgery. The hallmark of the disorder is markedly increased PLAU levels within platelets, which causes intraplatelet plasmin generation and secondary degradation of alpha-granule proteins.<ref>PMID:20007542</ref> | ||
- | == Function == | ||
- | [[http://www.uniprot.org/uniprot/UROK_HUMAN UROK_HUMAN]] Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin. | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 25: | Line 19: | ||
==See Also== | ==See Also== | ||
- | *[[Urokinase|Urokinase]] | + | *[[Urokinase 3D Structures|Urokinase 3D Structures]] |
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Homo sapiens]] |
- | [[Category: | + | [[Category: Large Structures]] |
- | [[Category: Andersen | + | [[Category: Andersen LM]] |
- | [[Category: Andreasen | + | [[Category: Andreasen PA]] |
- | [[Category: Botkjaer | + | [[Category: Botkjaer KA]] |
- | [[Category: Huang | + | [[Category: Huang M]] |
- | [[Category: Jiang | + | [[Category: Jiang L]] |
- | [[Category: Yuan | + | [[Category: Yuan C]] |
- | + | ||
- | + | ||
- | + | ||
- | + |
Current revision
The crystal structure of human urokinase-type plasminogen activator catalytic domain
|
Categories: Homo sapiens | Large Structures | Andersen LM | Andreasen PA | Botkjaer KA | Huang M | Jiang L | Yuan C